1. Home
  2. SPRC

as of 12-04-2025 3:35pm EST

$1.86
+$0.15
+8.80%
Stocks Health Care Biotechnology: Pharmaceutical Preparations Nasdaq

SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.

Chart Type:
Time Range:
Founded: 2004 Country:
Israel
Israel
Employees: N/A City: N/A
Market Cap: 4.0M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 2.6M
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: N/A EPS Growth: N/A
52 Week Low/High: $1.60 - $37.59 Next Earning Date: 01-01-0001
Revenue: $1,306,000 Revenue Growth: 187.98%
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

AI-Powered SPRC Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated a day ago

AI Recommendation

hold
Model Accuracy: 72.85%
72.85%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Share on Social Networks: